Desflurane-induced postconditioning is mediated by β-adrenergic signaling: Role of β1-and β2-adrenergic receptors, protein kinase A, and calcium/Calmodulin-dependent protein kinase II

Anesthesiology

Volumn 110, Issue 3, 2009, Pages 516-528

  Lange, Markus ^a   Redel, Andreas ^a   Lotz, Christopher ^a   Smul, Thorsten M ^a   Blomeyer, Christoph ^a   Frank, Anja ^a   Stumpner, Jan ^a   Roewer, Norbert ^a   Kehl, Franz ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Klinikum Karlsruhe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DESFLURANE; ESMOLOL; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PENTOBARBITAL; PHOSPHOLAMBAN; PROTEIN KINASE B; TRIPHENYLTETRAZOLIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ISOFLURANE; MALE; MYOCARDIAL INFARCTION; RABBITS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 62349120462     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318197ff62     Document Type: Article

References (50)

1. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007; 357:1121-35
2. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V: Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81:905-12
3. Schlack W, Preckel B, Stunneck D, Thamer V: Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998; 81:913-9
4. 2+ exchange inhibition in isolated hearts. Anesthesiology 2006; 105:541-9
5. Deyhimy Di, Fleming NW, Brodkin iG, Liu H: Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth Analg 2007; 105:316-24
6. Lange M, Smul TM, Blomeyer CA, Redel A, Klotz KN, Roewer N, Kehl F: Role of the adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo.ANESTHEsioLOGY 2006;105:503-10
7. Bayne K: Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996; 39:199, 208-11
8. Borkowski GL, Danneman PJ, Russell GB, Lang CM: An evaluation of three intravenous anesthetic regimens in New Zealand rabbits. Lab Anim Sci 1990; 40:270-6
9. Doorley BM, Waters SJ, Terrell RC, Robinson JL: MACofi-653 inbeagledogs and New Zealand white rabbits. Anesthesiology 1988; 69:89-91
10. iriki M, Riedel W, Simon E: Regional differentiation of sympathetic activity during hypothalamic heating and cooling in anesthetized rabbits. Pflugers Arch 1971; 328:320-31
11. Warltier DC, Zyvoloski MG, Gross GJ, Hardman HF, Brooks HL: Determination of experimental myocardial infarct size. J Pharmacol Methods 1981; 6:199-210
12. Lameris TW, de Zeeuw S, Alberts G, Boomsma F, Duncker DJ, Verdouw PD, Veld AJM, van den Meiracker AH: Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation 2000; 101: 2645-50
13. Thandroyen FT, Muntz KH, Buja LM, Willerson JT: Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion Circulation 1990; 82:ii30-7
14. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG: Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury.
15. J Biol Chem 2006; 281:2061-70
16. Spear JF, Prabu SK, Galati D, Raza H, Anandatheerthavarada HK, Avadhani NG: 1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning. Am J Physiol Heart Circ Physiol 2007; 292:H2459-66
17. Galcera-Tomas J, Castillo-Soria FJ, Villegas-Garcia MM, Florenciano-Sanchez R, Sanchez-Villanueva JG, de La Rosa JA, Martinez-Caballero A, Valenti-Aldeguer JA, Jara-Perez P, Parraga-Ramirez M, Lopez-Martinez i, inigo-Garcia L, Pico-Aracil F: Effects of early use of atenolol or captopril on infarct size and ventricular volume: A double-blind comparison in patients with anterior acute myocardial infarction. Circulation 2001; 103:813-9
18. FeuersteinG, Liu GL, Yue TL, ChengHY, Hieble JP, ArchJR, Ruffolo RRJr, Ma XL: Comparison of metoprolol and carvedilol pharmacology and cardiopro-tection in rabbit ischemia and reperfusion model. Eur J Pharmacol 1998; 351: 341-50
19. Frances C, Nazeyrollas P, Prevost A, Moreau F, Pisani J, Davani S, Kantelip JP, MillartH: Role ofbeta1-and beta2-adrenoceptor subtypes in preconditioningagainst myocardial dysfunction after ischemia and reperfusion. J Cardiovasc Pharmacol 2003; 41:396-405
20. Ebert TJ, Muzi M: Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers: A comparison with isoflurane. Anesthesiology 1993; 79: 444-53
21. igarashi N, Nozawa T, Fujii N, Suzuki T, Matsuki A, Nakadate T, igawa A, Inoue H: Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury. Circ J 2006; 70:1509-14
22. Takeo S, Yamada H, Tanonaka K, Hayashi M, Sunagawa N: Possible involvement of membrane-stabilizing action in beneficial effect of beta adrenocep-tor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther 1990; 254:847-56
23. Trotz M, Jellison EJ, Hostetler KY: Propranolol inhibition of the neutral phospholipases A of rat heart mitochondria, sarcoplasmic reticulum and cytosol. Biochem Pharmacol 1987; 36:4251-6
24. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H: Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 2004; 25:358-65
25. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P: opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001; 276:2571-5
26. Griffiths EJ, Halestrap AP: Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995; 307(pt 1):93-8
27. Halestrap AP: Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans 2006; 34:232-7
28. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC: Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: Evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005; 102:102-9
29. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS: Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: The role of mitochondrial KATP channels. Anesth Analg 2005; 101:1590-6
30. Piriou V, Chiari P, Gateau-Roesch O, Argaud L, Muntean D, Salles D, Loufouat J, Gueugniaud PY, Lehot JJ, Ovize M: Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 2004; 100:581-8
31. Makaula S, Lochner A, Genade S, Sack MN, Awan MM, Opie LH: H-89, a non-specific inhibitor of protein kinase A, promotes post-ischemic cardiac contractile recoveryand reduces infarctsize. JCardiovasc Pharmacol2005; 45:341-7
32. Sanada S, Asanuma H, Tsukamoto o, Minamino T, Node K, Takashima S, Fukushima T, Ogai A, Shinozaki Y, Fujita M, Hirata A, Okuda H, Shimokawa H, Tomoike H, Hori M, Kitakaze M: Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 2004; 110:51-7
33. Redel A, Lange M, Jazbutyte V, Lotz C, Smul TM, Roewer N, Kehl F: Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning. Anesth Analg 2008; 106:384-91
34. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE Jr, Thiel W, Guatimosim S, Song LS, Madu EC, Shah AN, Vishnivetskaya TA, Atkinson JB, Gurevich VV, Salama G, Lederer WJ, Colbran RJ, Anderson ME: Calmodulin kinase ii inhibition protects against structural heart disease. Nat Med 2005; 11:409-17
35. Wang W, Zhu W, Wang S, Yang D, Crow MT, Xiao RP, Cheng H: Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodu-lin kinase signaling pathway. Circ Res 2004; 95:798-806
36. Yang Y, Zhu WZ, Joiner ML, Zhang R, Oddis CV, Hou Y, Yang J, Price EE, Gleaves L, Eren M, Ni G, Vaughan DE, Xiao RP, Anderson ME: Calmodulin kinase ii inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol 2006; 291:H3065-75
37. Hoch B, Meyer R, Hetzer R, Krause EG, Karczewski P: Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 1999; 84:713-21
38. Mattiazzi A, Vittone L, Mundina-Weilenmann C: Ca2+/calmodulin-depen-dent protein kinase: A key component in the contractile recovery from acidosis. Cardiovasc Res 2007; 73:648-56
39. Nomura N, Satoh H, Terada H, Matsunaga M, Watanabe H, Hayashi H: CaMKII-dependent reactivation of SR Ca(2+) uptake and contractile recovery during intracellular acidosis. Am J Physiol Heart Circ Physiol 2002; 283:H193-203
40. Benter IF, Juggi JS, Khan I, Yousif MH, Canatan H, Akhtar S: Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GT-Pase, Ca2 +/calmodulin-dependent protein kinase II and epidermal growth factor receptor. Mol Cell Biochem 2005; 268:175-83
41. Lange M, Smul TM, Redel A, Lotz C, Jazbutyte V, Schnupp V, Roewer N, Kehl F: Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: Met-oprolol blocks desflurane-induced preconditioning. Anesthesiology 2008; 109: 72-80
42. Maier LS, Bers DM: Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007; 73:631-40
43. An J, Bosnjak ZJ, Jiang MT: Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels. Anesth Analg 2007; 105:1207-13
44. Arlock P, Wohlfart B, Sjoberg T, Steen S: The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J 2005; 39:250-4
45. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351:95-105
46. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquino- linesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265:5267-72
47. Sun PW, Kyoung SY, Kim N, Boum YJ, Joo H, Warda M, Ko JH, Earm YE, Han J: The protein kinase A inhibitor, H-89, directly inhibits KATP and Kir channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun 2006; 340:1104-10
48. Uemura A, Naito Y, Matsubara T: Dynamics of Ca(2+)/calmodulin-dependent protein kinase II following acute myocardial ischemia-translocation and autophosphorylation. Biochem Biophys Res Commun 2002; 297: 997-1002
49. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H: The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 1991; 181:968-75
50. Anderson ME, Braun AP, Wu Y, Lu T, Wu Y, Schulman H, Sung RJ: KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther 1998; 287:996-1006